Found: 4
Select item for more details and to access through your institution.
Unusual side effect from a luteinizing hormone-releasing hormone agonist, leuprorelin, in the treatment of prostate cancer: a case report.
- Published in:
- Journal of Medical Case Reports, 2016, v. 10, p. 1, doi. 10.1186/s13256-016-1110-5
- By:
- Publication type:
- Article
Impact on genitourinary function and quality of life following focal irreversible electroporation of different prostate segments.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Pair-matched patient-reported quality of life and early oncological control following focal irreversible electroporation versus robot-assisted radical prostatectomy.
- Published in:
- World Journal of Urology, 2018, v. 36, n. 9, p. 1383, doi. 10.1007/s00345-018-2281-z
- By:
- Publication type:
- Article
Diagnostic accuracy of <sup>68</sup>Ga‐prostate‐specific membrane antigen (PSMA) positron‐emission tomography (PET) and multiparametric (mp)MRI to detect intermediate‐grade intra‐prostatic prostate cancer using whole‐mount pathology: impact of the addition of <sup>68</sup>Ga‐PSMA PET to mpMRI
- Published in:
- BJU International, 2019, v. 124, p. 42, doi. 10.1111/bju.14794
- By:
- Publication type:
- Article